Randomized phase III study of nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung
- Conditions
- squamous cell carcinoma of the lung
- Registration Number
- JPRN-UMIN000002015
- Lead Sponsor
- West Japan Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 350
Not provided
1)Symptomatic brain metastasis or brain metastasis which needs treatment like adrenal corticosteroids or antiepileptic drugs. 2)Other current active malignancy. 3)Superior vena cava syndrome. 4)Malignant pericardial/ pleural/ peritoneal effusion which need continuous drainage or rapidly increase after temporary drainage. 5)Patient has received radiotherapy to the primary lesion. 6)Patient received palliative radiotherapy except to the primary lesion in last 2 weeks. 7)Patient has a clinically significant con current illness. 8)Interstitial pneumonia or pulmonary fibrosis documented obviously in chest X ray. 9)Pregnant or breast-feeding woman or patient who doesn't agree to contraception. 10)Patient has a history of severe allergy or hypersensitivity. 11)Any other reason that, in the opinion of the investigator, precludes the subject from participating in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method